News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
546,163 Results
Type
Article (14131)
Company Profile (148)
Press Release (531882)
Multimedia
Podcasts (84)
Webinars (7)
Section
Business (182722)
Career Advice (586)
Deals (28665)
Drug Delivery (34)
Drug Development (63146)
Employer Resources (24)
FDA (11562)
Job Trends (9831)
News (266949)
Policy (21052)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (866)
Accelerated approval (37)
ADA (20)
Adcomms (15)
Allergies (124)
Alliances (36876)
ALS (151)
Alzheimer's disease (1155)
Antibody-drug conjugate (ADC) (460)
Approvals (12156)
Artificial intelligence (427)
ASCO (239)
Autoimmune disease (267)
Automation (34)
Bankruptcy (279)
Best Places to Work (8053)
BIO (47)
BIOSECURE Act (4)
Biosimilars (152)
BioSpace Insights (100)
Biotechnology (100)
Bladder cancer (158)
Brain cancer (45)
Breast cancer (655)
Cancer (4906)
Cardiovascular disease (283)
Career advice (469)
Career pathing (10)
CAR-T (280)
CDC (13)
Celiac Disease (2)
Cell therapy (690)
Cervical cancer (42)
Clinical research (56565)
Collaboration (1569)
Commercialization (3)
Compensation (1498)
Complete response letters (50)
COVID-19 (1169)
CRISPR (80)
C-suite (883)
Cystic fibrosis (107)
Data (7171)
Decentralized trials (1)
Denatured (75)
Depression (121)
Dermatology (71)
Diabetes (411)
Diagnostics (4933)
Digital health (42)
Diversity (6)
Diversity, equity & inclusion (7)
Drug discovery (223)
Drug pricing (43)
Drug shortages (6)
Duchenne muscular dystrophy (265)
Earnings (80182)
Editorial (23)
Employer branding (2)
Employer resources (25)
Events (95988)
Executive appointments (817)
FDA (14811)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (25)
Funding (1109)
Gene editing (171)
Generative AI (17)
Gene therapy (512)
GLP-1 (420)
Government (1421)
Grass and pollen (2)
Guidances (355)
Healthcare (11056)
Hematology (125)
HIV (59)
Huntington's disease (40)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (95)
Immunology and inflammation (131)
Immuno-oncology (81)
Indications (194)
Infectious disease (1394)
Inflammatory bowel disease (163)
Inflation Reduction Act (7)
Influenza (99)
Intellectual property (289)
Interviews (119)
IPO (13973)
IRA (11)
Job creations (2146)
Job search strategy (404)
JPM (19)
Kidney cancer (20)
Labor market (20)
Layoffs (123)
Leadership (6)
Legal (5639)
Licensing (8)
Liver cancer (65)
Longevity (19)
Lung cancer (675)
Lymphoma (360)
Machine learning (38)
Management (9)
Manufacturing (677)
Marketing (10)
MASH (164)
Medical device (9715)
Medtech (9875)
Mergers & acquisitions (15717)
Metabolic disorders (896)
mRNA (119)
Multiple sclerosis (155)
NASH (9)
Neurodegenerative disease (292)
Neuropsychiatric disorders (49)
Neuroscience (2278)
NextGen: Class of 2026 (3520)
Non-profit (1116)
Now hiring (18)
Obesity (294)
Opinion (52)
Ovarian cancer (202)
Pain (208)
Pancreatic cancer (284)
Parkinson's disease (253)
Partnered (19)
Patents (564)
Patient recruitment (660)
Peanut (35)
People (44481)
Pharmaceutical (33)
Pharmacy benefit managers (26)
Phase 1 (18275)
Phase 2 (25221)
Phase 3 (17561)
Pipeline (8840)
Policy (85)
Postmarket research (1769)
Preclinical (7903)
Press Release (72)
Prostate cancer (250)
Psychedelics (18)
Radiopharmaceuticals (246)
Rare diseases (788)
Real estate (3287)
Recruiting (13)
Regulatory (17933)
Reports (27)
Research institute (921)
Resumes & cover letters (81)
Rett syndrome (44)
RNA editing (25)
RSV (53)
Schizophrenia (122)
Series A (184)
Series B (135)
Service/supplier (5)
Sickle cell disease (88)
Special edition (2)
Spinal muscular atrophy (110)
Sponsored (14)
Startups (2221)
State (1)
Stomach cancer (11)
Supply chain (66)
Tariffs (3)
The Weekly (8)
Vaccines (537)
Venture capital (38)
Weight loss (115)
Women's health (90)
Worklife (5)
Date
Today (119)
Last 7 days (614)
Last 30 days (1956)
Last 365 days (23395)
2026 (14606)
2025 (23310)
2024 (27387)
2023 (31353)
2022 (39690)
2021 (42516)
2020 (38119)
2019 (26940)
2018 (20569)
2017 (21822)
2016 (20370)
2015 (26760)
2014 (23496)
2013 (19551)
2012 (21542)
2011 (21890)
2010 (21661)
Location
Africa (306)
Alabama (75)
Alaska (3)
Arizona (325)
Arkansas (13)
Asia (25360)
Australia (3331)
California (12772)
Canada (3714)
China (953)
Colorado (527)
Connecticut (510)
Delaware (276)
Europe (43217)
Florida (1896)
Georgia (391)
Hawaii (3)
Idaho (46)
Illinois (819)
India (70)
Indiana (407)
Iowa (15)
Japan (542)
Kansas (104)
Kentucky (31)
Louisiana (31)
Maine (68)
Maryland (1344)
Massachusetts (8949)
Michigan (324)
Minnesota (600)
Mississippi (4)
Missouri (118)
Montana (20)
Nebraska (11)
Nevada (137)
New Hampshire (64)
New Jersey (3160)
New Mexico (19)
New York (3211)
North Carolina (1435)
North Dakota (6)
Northern California (6397)
Ohio (304)
Oklahoma (17)
Oregon (19)
Pennsylvania (2523)
Puerto Rico (20)
Rhode Island (32)
South America (571)
South Carolina (79)
South Dakota (1)
Southern California (5247)
Tennessee (123)
Texas (2110)
United States (43218)
Utah (375)
Vermont (1)
Virginia (264)
Washington D.C. (43)
Washington State (985)
West Virginia (1)
Wisconsin (82)
546,163 Results for "express scripts inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Milestone Pharmaceuticals Announces that CARDAMYST™ (etripamil) Nasal Spray is Available on Express Scripts Commercial National Formularies
March 31, 2026
·
8 min read
Press Releases
Accord BioPharma’s HERCESSI™ (trastuzumab-strf) Gains Preferred Status on Express Scripts National Commercial Formularies
January 5, 2026
·
8 min read
Press Releases
Accord BioPharma’s IMULDOSA® (ustekinumab-srlf) Added to Express Scripts National Commercial Formularies
December 2, 2025
·
9 min read
Press Releases
GeneCentric Launches ExpressCT Rewind™ to Unlock Gene Expression Insights from Existing Liquid Biopsy DNA Sequencing
July 8, 2026
·
2 min read
Business
Express Scripts Sues FTC, Demands Withdrawal of ‘False and Misleading’ PBM Report
Pharmacy benefit manager Express Scripts announced Tuesday it has filed a lawsuit in federal court in Missouri against the Federal Trade Commission for its “unfair, biased and erroneous” July report on the industry.
September 17, 2024
·
2 min read
·
Kate Goodwin
BioMidwest
Express Scripts enhances strategies to support access to care at independent pharmacies
Express Scripts, the pharmacy benefits services business of The Cigna Group’s Evernorth, is making it easier for people to access a broader range of care services at independent pharmacies.
May 23, 2024
·
3 min read
Press Releases
GenScript Launches TurboCHO™ Protein Expression Kit, Delivering the Fastest Path to Antibodies in its Class
May 12, 2026
·
4 min read
Press Releases
Flipping the script: Scripta Therapeutics raises $12M to find disease-modifying drugs that alter transcription factor activity
November 13, 2025
·
3 min read
Press Releases
DNA Script Expands Global Access to On-demand DNA Synthesis With Distributor Agreements in Latin America and East Asia
March 17, 2026
·
2 min read
Earnings
All Eyes on Vertex’s Kidney Franchise, as Painkiller Journavx Tops Half a Million Scripts
Analysts are keeping a close eye on Vertex’s kidney disease portfolio, anchored by the IgAN drug povetacicept, as its nonopioid painkiller Journavx is poised for “incremental” growth in the first half 2026, according to BMO Capital Markets.
February 13, 2026
·
2 min read
·
Tristan Manalac
1 of 54,617
Next
